HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Indoleamine 2,3-dioxygenase-dependent tryptophan metabolites contribute to tolerance induction during allergen immunotherapy in a mouse model.

AbstractBACKGROUND:
The tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO) has been implicated in immune suppression and tolerance induction.
OBJECTIVE:
We examined (1) whether IDO activity is required during tolerance induction by allergen immunotherapy or for the subsequent suppressive effects on asthma manifestations and (2) whether tryptophan depletion or generation of its downstream metabolites is involved.
METHODS:
Ovalbumin (OVA)-sensitized and OVA-challenged BALB/c mice that display increased airway responsiveness to methacholine, serum OVA-specific IgE levels, bronchoalveolar eosinophilia, and TH2 cytokine levels were used as a model of allergic asthma. Sensitized mice received subcutaneous optimal (1 mg) or suboptimal (100 microg) OVA immunotherapy.
RESULTS:
Inhibition of IDO by 1-methyl-DL-tryptophan during immunotherapy, but not during inhalation challenge, partially reversed the suppressive effects of immunotherapy on airway eosinophilia and TH2 cytokine levels, whereas airway hyperresponsiveness and serum OVA-specific IgE levels remained suppressed. Administration of tryptophan during immunotherapy failed to abrogate its beneficial effects toward allergic airway inflammation. Interestingly, administration of tryptophan or its metabolites, kynurenine, 3-hydroxykynurenine, and xanthurenic acid, but not 3-hydroxyanthranilinic acid, quinolinic acid, and kynurenic acid, during suboptimal immunotherapy potentiated the reduction of eosinophilia. These effects coincided with reduced TH2 cytokine levels in bronchoalveolar lavage fluid, but no effects on IgE levels were detected.
CONCLUSION:
During immunotherapy, the tryptophan metabolites kynurenine, 3-hydroxykynurenine, and xanthurenic acid generated through IDO contribute to tolerance induction regarding TH2-dependent allergic airway inflammation.
AuthorsYousef A Taher, Benoit J A Piavaux, Reneé Gras, Betty C A M van Esch, Gerard A Hofman, Nanne Bloksma, Paul A J Henricks, Antoon J M van Oosterhout
JournalThe Journal of allergy and clinical immunology (J Allergy Clin Immunol) Vol. 121 Issue 4 Pg. 983-91.e2 (Apr 2008) ISSN: 1097-6825 [Electronic] United States
PMID18179817 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cytokines
  • Indoleamine-Pyrrole 2,3,-Dioxygenase
  • Tryptophan
Topics
  • Animals
  • Bronchoalveolar Lavage Fluid (cytology, immunology)
  • Cytokines (blood)
  • Desensitization, Immunologic (methods)
  • Disease Models, Animal
  • Eosinophilia (immunology, prevention & control)
  • Immune Tolerance
  • Indoleamine-Pyrrole 2,3,-Dioxygenase (physiology)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Respiratory Hypersensitivity (enzymology, immunology, pathology, therapy)
  • Th2 Cells (enzymology, immunology, metabolism)
  • Tryptophan (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: